Segmentation by type classifies Cosmetic Efficacy Evaluation Services according to the methodological approach employed. The principal types are in‑vitro biochemical assays (35%), ex‑vivo skin model testing (20%), instrumental analysis (e.g., spectroscopic, imaging) (25%), controlled clinical trials (15%) and consumer perception studies (5%). In‑vitro assays dominate due to their cost‑effectiveness and rapid turnaround, supporting early‑stage claim substantiation. Ex‑vivo models provide a bridge between laboratory and human data, particularly for barrier function metrics. Instrumental analysis offers quantitative endpoints such as elasticity or reflectance, essential for objective claim verification. Clinical trials, though resource‑intensive, are indispensable for regulatory compliance in high‑risk categories. Consumer perception studies, while a minor share, add qualitative insight into user experience. This type‑based taxonomy clarifies how each methodological segment underpins the total market valuation by aligning service complexity, regulatory stringency, and client budgetary considerations.